AMERICAN SOCIETY OF NEPHROLOGY LAUNCHES THE GLOMERULAR DISEASES COLLABORATIVE (GD-C) TO ADDRESS GAPS IN KNOWLEDGE AND BARRIERS IN THE CARE OF PEOPLE WITH GLOMERULAR DISEASES

Chronic kidney disease is a progressive condition that affects more than 10% of the general population worldwide, amounting to 800 million individuals.1 Glomerular diseases (GD), excluding diabetic nephropathy, account for approximately 25% of the cases of kidney diseases worldwide.2 Given the magnitude of long-term morbidity from GD— particularly the frequent manifestation in younger patients—diagnosing it efficiently and optimizing management to control diseases and prevent progressive kidney diseases is paramount.